This Week’s Biopharma News: ADCs, Biosimilars, and Microbiome Moves - Top-Institutions - MDSpire

This Week’s Biopharma News: ADCs, Biosimilars, and Microbiome Moves

  • May 26, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Cancer
    • Pharmacology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Cancer
    • Pharmacology

  • #3

    Tufts Center for the Study of Drug Development
    Tufts Center for the Study of Drug Development

    Boston, Massachusetts

    Key Differentiators

    • Pharmacology
    • Drug Development

  • #4

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Key Differentiators

    • Ophthalmology
    • Pharmacology

  • #5

    Retina Consultants of Houston
    Retina Consultants of Houston

    Houston, Texas

    Key Differentiators

    • Ophthalmology
    • Pharmacology

Original Source(s)

This Week’s Biopharma News: ADCs, Biosimilars, and Microbiome Moves

  • May 26, 2026

Related Content

Beyond Nodule Detection: AI, Chest CT, and a Vision for Population Health

Lung cancer resulted in 1.8 million deaths globally in 2022 and remains the leading cause of cancer-related mortality worldwide. Low-dose CT screening has been shown to reduce lung cancer mortality, a...

Preclinical Study in Mice Addresses a Question: Should RAS Inhibitors Be Given Preemptively?

With recent data that RAS inhibition can improve survival in metastatic pancreatic cancer, the optimization of these agents has become a research priority. Minh Than, MD, PhD, a clinical and research ...

2026 NCCN Clinical Practice Guidelines in Oncology®: Key Updates Across Tumor Types

The National Comprehensive Cancer Network® (NCCN®) first introduced the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in 1996, initially covering eight tumor types. Three decades la...